Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 19/20 | 0.84 |
| ▸ | PLA2G1B | P04054 | 8/20 | 0.84 |
| ▸ | PLA2G10 | O15496 | 8/20 | 0.84 |
| ▸ | PLA2G2E | Q9NZK7 | 8/20 | 0.84 |
| ▸ | PLA2G5 | P39877 | 7/20 | 0.84 |
| ▸ | PLA2G2F | Q9BZM2 | 5/20 | 0.78 |
| ▸ | PLA2G2D | Q9UNK4 | 5/20 | 0.78 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.78 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.78 |
| ▸ | PLA2G12B | Q9BX93 | 1/20 | 0.78 |
| ▸ | PLA2G12A | Q9BZM1 | 1/20 | 0.78 |
| ▸ | PLA2G3 | Q9NZ20 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8040246 | 0.94 | PLA2G2A (0.81) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL5790532 | 0.91 | PLA2G2A (1.00) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL8503435 | 0.90 | PLA2G2A (0.98) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL8503441 | 0.90 | PLA2G2A (0.98) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL5788255 | 0.90 | PLA2G2A (0.81) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL7171715 | 0.90 | PLA2G2A (0.81) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL8035727 | 0.90 | PLA2G2A (0.77) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL8024037 | 0.89 | PLA2G2A (0.78) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL7164079 | 0.89 | PLA2G2A (0.78) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| Varespladib SCHEMBL29358982 | 0.88 | PLA2G2A (1.00) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6617460-B1 | 5-hydrocarbylsulfoxy-4,5,6,7-tetrahydroindol-4-one intermediates useful in the preparation of 1H-indole-3-glyoxamides. | ELI LILLY AND COMPANY | 2003-09-09 | — | — | US | disclosed |
| US-6570023-B1 | Chemical intermediate for drug to threat sepsis shock, rheumatic diseases | ELI LILLY AND COMPANY | 2003-05-27 | — | — | US | disclosed |
| US-6380397-B1 | HALOGENATION AN OXOESTER COMPOUND; HYDROLYSIS AND DECARBOXYLATION; ALKYLATION; AMINATION; REACTING OXALY CHLORIDE | ELI LILLY AND COMPANY | 2002-04-30 | — | — | US | disclosed |
| US-6265591-B1 | HALOGENATING KETO ESTER COMPOUND; HYDROLYSIS AND DECARBOXYLATION; ALKYLATING; AMINATION AND DEHYDRATION TO FORM TRIKETO COMPOUND; AMINATING; OXIDATION, ALKYLATING; REACTING INDOLE DERIVATIVE WITH OXALYL CHLORIDE AND AMMONIA | ELI LILLY AND COMPANY | 2001-07-24 | — | — | US | disclosed |
| US-5986106-A | Process for preparing 4-substituted-1H-indole-3-glyoxamides | ELI LILLY AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| EP-0887342-A2 | Process for preparing 4-substituted-1H-indole-3-glyoxamides | ELI LILLY AND COMPANY (US) | 1998-12-30 | — | — | EP | disclosed |